Overlapping syndrome of autoimmune hepatitis and primary sclerosing cholangitis associated with pyoderma gangrenosum and ulcerative colitis

European Journal of Gastroenterology and Hepatology

Volumn 11, Issue 12, 1999, Pages 1421-1424

  Koskinas, John ^a   Raptis, Irene ^a   Manika, Zisoula ^b   Hadziyannis, Stephanos ^a  

^a HIPPOKRATION HOSPITAL   (Greece)

^b RED CROSS HOSPITAL   (Greece)

Author keywords

Autoimmune hepatitis; Overlap syndrome; Primary sclerosing cholangitis; Pyoderma gangrenosum

Indexed keywords

ANTINUCLEAR ANTIBODY; AZATHIOPRINE; CYCLOSPORIN; URSODEOXYCHOLIC ACID;

ADULT; ANTIBODY TITER; ARTICLE; AUTOIMMUNE HEPATITIS; CHOLANGITIS; DIARRHEA; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER TRANSPLANTATION; LYMPHADENOPATHY; MALE; NORMAL HUMAN; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PRURITUS; PYODERMA GANGRENOSUM; SCORING SYSTEM; SYNDROME; ULCERATIVE COLITIS;

EID: 0033405987     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-199912000-00014     Document Type: Article

References (26)

1. 1 Johnson PJ, McFarlane IG. Meeting report: International Autoimmune Hepatitis Group. Hepatology 1993; 18:998-1005.
2. 2 Lee YM, Kaplan M. Primary sclerosing cholangitis. W Engl J Med 1995; 332:924-933.
3. 3 Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996; 334:897-903.
4. 4 Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996; 125:588-598.
5. 5 Chapman RW, Cottone M, Selby WS, Shepherd HA, Sherlock S, Jewell DP. Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis. Gut 1986; 27:86-91.
6. 6 Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid treated autoimmune hepatitis. J Hepatol 1992; 14:325-331.
7. 7 El-Shabrawi M, Wilkinson M, Portmann B, et al. Primary sclerosing cholangitis in childhood. Gastroentemlogy 1987; 92:1226-1235.
8. 8 Wilschanki M, Chait P, Wade JA, et al. Primary sclerosing cholangitis in 32 children: clinical, laboratory and radiographie findings with survival analysis. Hepatology 1995; 22:1414-1420.
9. 9 Minuk GY, Sutherland LR, Pappas SC, Kelly JK, Martin SE. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988; 2:22-27.
10. 10 Leggett BA, Hallam A, Powell EE, Powell LW. Autoimmune chronic active hepatitis evolving to primary sclerosing cholangitis: evidence for a common pathogenesis (Abstract). Hepatology 1992; 16:191A.
11. 11 Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992; 37:1606-1611.
12. 12 Lawrence SP, Sherman KE, Lawson JM, Goodman ZY. A 38 year old man with chronic hepatitis. Sem Liver Dis 1994; 14:97-105.
13. 13 Wurbs D, Klein R, Terracciano LM, Berg PA, Bianchi L. A 28 year old woman with a combined hepatitic/cholestatic syndrome. Hepatology 1995; 22:1598-1605.
14. 14 Gohlke F, Lohse A, Dienes H, Maerker-Hermann E, Gerken G, Meyer Karl-Hermann zum Bueschenfelde. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24:699-705.
15. 15 Rabinovitz M, Gavaler J, Schade R, Dindzans V, Chien MC, Van Thiel D. Does primary sclerosing cholangitis occurring in association with inflammatory bowel disease differ from that occurring in the absence of inflammatory bowel disease? A study of sixty-six subjects. Hepatology 1990; 11:7-11.
16. 16 Fausa O, Schrumpf E, Elgio K. Relationship of inflammatory bowel disease and primary sclerosing cholangitis. Sem Liver Dis 1991; 11:31-39.
17. 17 Prystowski J, Kahn S, Lazarus G. Present status of pyoderma gangrenosum. Arch Dermatol 1989; 125:57-64.
18. 18 Byrne J, Hewitt M. Pyoderma gangrenosum associated with active chronic hepatitis. Arch Dermatol 1976; 112:1297-1301.
19. 19 Green LK, Hebert AA, Jorizzo JL, Solomon AR Jr, Subramanyam K. Pyoderma gangrenosum and chronic persistent hepatitis. J Am Acad Dermatol 1985; 13:892-897.
20. 20 Burns DA, Sarkany I. Active chronic hepatitis and pyoderma gangrenosum: report of a case. Clin Exp Dermatol 1979; 4:465-469.
21. 21 Marshall AW, Slonim JM, Smallwood RA, Fraser KJ. The association of chronic active hepatitis with pyoderma gangrenosum. Austr NZ J Med 1978; 8:656-658.
22. 22 Byrne JP, Hewitt M, Summerly R. Pyoderma gangrenosum associated with active chronic hepatitis: report of two cases. Arch Dermatol 1976; 112:1297-1301.
23. 23 Sampson JA, Harris OD, Van Deth AG. Pyoderma gangrenosum and chronic active hepatitis: a case report, Australas J Dermatol 1982; 23:93-96.
24. 24 Donalson PT. Immunogenetics in liver disease. Baillière's Clin Gastroenterol 1996; 10:534-549.
25. 25 Mieli-Vergani G, Lobo-Yeo A, McFarlane BM, McFarlane IG, Mowat AP, Vergani D. Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood. Hepatology 1989; 9:198-203.
26. 26 Farrant IM, Mayllar KM, Wilkinson ML, Karani J, Portmann BC, Westaby D, et al. Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology 1991; 100:1710-1717.